Li Jia

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Venues

Nature communications

The Prostate

Molecular cancer research : MCR

Proceedings of the National Academy of Sciences of the United States of America

Brigham and Women's Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Brigham and Women's Hospital

United States

Assistant Professor :: Surgery

Publications

Fu Gui, Baishan Jiang, Jie Jiang, Zhixiang He, Takuya Tsujino, Tomoaki Takai, Seiji Arai, Celine Pana, Jens Köllermann, Gary Andrew Bradshaw, Robyn Eisert, Marian Kalocsay, Anne Fassl, Steven P Balk, Adam S Kibel, Li Jia
Acute BRCAness Induction and AR Signaling Blockage through CDK12/7/9 Degradation Enhances PARP Inhibitor Sensitivity in Prostate Cancer. bioRxiv : the preprint server for biology (2024)
Takuya Tsujino, Tomoaki Takai, Kunihiko Hinohara, Fu Gui, Takeshi Tsutsumi, Xiao Bai, Chenkui Miao, Chao Feng, Bin Gui, Zsofia Sztupinszki, Antoine Simoneau, Ning Xie, Ladan Fazli, Xuesen Dong, Haruhito Azuma, Atish D Choudhury, Kent W Mouw, Zoltan Szallasi, Lee Zou, Adam S Kibel, Li Jia
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer. Nature communications 14 (1) (2023)
Takuya Tsujino, Tomoaki Takai, Kunihiko Hinohara, Fu Gui, Takeshi Tsutsumi, Xiao Bai, Chenkui Miao, Chao Feng, Bin Gui, Zsofia Sztupinszki, Antoine Simoneau, Ning Xie, Ladan Fazli, Xuesen Dong, Haruhito Azuma, Atish D Choudhury, Kent W Mouw, Zoltan Szallasi, Lee Zou, Adam S Kibel, Li Jia
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer. Nature communications 14 (1) (2023)
Takuya Tsujino, Tomoaki Takai, Kunihiko Hinohara, Fu Gui, Takeshi Tsutsumi, Xiao Bai, Chenkui Miao, Chao Feng, Bin Gui, Zsofia Sztupinszki, Antoine Simoneau, Ning Xie, Ladan Fazli, Xuesen Dong, Haruhito Azuma, Atish D Choudhury, Kent W Mouw, Zoltan Szallasi, Lee Zou, Adam S Kibel, Li Jia
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer. Nature communications 14 (1) (2023)
Takuya Tsujino, Tomoaki Takai, Kunihiko Hinohara, Fu Gui, Takeshi Tsutsumi, Xiao Bai, Chenkui Miao, Chao Feng, Bin Gui, Zsofia Sztupinszki, Antoine Simoneau, Ning Xie, Ladan Fazli, Xuesen Dong, Haruhito Azuma, Atish D Choudhury, Kent W Mouw, Zoltan Szallasi, Lee Zou, Adam S Kibel, Li Jia
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer. Nature communications 14 (1) (2023)
Takuya Tsujino, Tomoaki Takai, Kunihiko Hinohara, Fu Gui, Takeshi Tsutsumi, Xiao Bai, Chenkui Miao, Chao Feng, Bin Gui, Zsofia Sztupinszki, Antoine Simoneau, Ning Xie, Ladan Fazli, Xuesen Dong, Haruhito Azuma, Atish D Choudhury, Kent W Mouw, Zoltan Szallasi, Lee Zou, Adam S Kibel, Li Jia
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer. Nature communications 14 (1) (2023)
Takuya Tsujino, Tomoaki Takai, Kunihiko Hinohara, Fu Gui, Takeshi Tsutsumi, Xiao Bai, Chenkui Miao, Chao Feng, Bin Gui, Zsofia Sztupinszki, Antoine Simoneau, Ning Xie, Ladan Fazli, Xuesen Dong, Haruhito Azuma, Atish D Choudhury, Kent W Mouw, Zoltan Szallasi, Lee Zou, Adam S Kibel, Li Jia
CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer. Nature communications 14 (1) (2023)
Chenkui Miao, Takuya Tsujino, Tomoaki Takai, Fu Gui, Takeshi Tsutsumi, Zsófia M Sztupinszki, Zengjun Wang, Haruhito Azuma, Zoltan Szallasi, Kent W Mouw, Lee Zou, Adam S Kibel, Li Jia
RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer. Science advances 8 (7) (2022)
Bin Gui, Fu Gui, Tomoaki Takai, Chao Feng, Xiao Bai, Ladan Fazli, Xuesen Dong, Shuai Liu, Xiaofeng Zhang, Wei Zhang, Adam S Kibel, Li Jia
Selective targeting of PARP-2 inhibits androgen receptor signaling and prostate cancer growth through disruption of FOXA1 function. Proceedings of the National Academy of Sciences of the United States of America 116 (29) (2019)
Ilker Tinay, Mingyue Tan, Bin Gui, Lillian Werner, Adam S Kibel, Li Jia
Functional roles and potential clinical application of miRNA-345-5p in prostate cancer. The Prostate 78 (12) (2018)
Shahrzad Rafiei, Bin Gui, Jiaxin Wu, X Shirley Liu, Adam S Kibel, Li Jia
Targeting the MIF/CXCR7/AKT Signaling Pathway in Castration-Resistant Prostate Cancer. Molecular cancer research : MCR 17 (1) (2018)
Li Jia, Bin Gui, Dali Zheng, Keith F Decker, Ilker Tinay, Mingyue Tan, Xiaowei Wang, Adam S Kibel
Androgen receptor-regulated miRNA-193a-3p targets AJUBA to promote prostate cancer cell migration. The Prostate 77 (9) (2017)
Bin Gui, Chen-Lin Hsieh, Philip W Kantoff, Adam S Kibel, Li Jia
Androgen receptor-mediated downregulation of microRNA-221 and -222 in castration-resistant prostate cancer. PloS one 12 (9) (2017)

Li Jia.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Li Jia